As of Monday, August 1, doctors no longer need to go through the FOPH to prescribe cannabis to their patients – previously they had to apply for an exceptional permit, a long and laborious process. This change in practice should improve the quality of life for patients with neurological disease or cancer when traditional medicine struggles to overcome their pain and nausea. Switzerland is cautiously opening the door to a vast and hitherto unexplored area of research.
Why is this remarkable. The FOPH estimates that the number of patients using cannabis for therapeutic purposes should triple after this change in practice, which has so far issued 2,500 to 3,000 exclusive permits per year.
Reserved for subscribers
This article is for subscribers only.